Print

Sagent Pharmaceuticals, Inc. Reports Second Quarter 2012 Financial Results  
8/9/2012 9:40:12 AM

SCHAUMBURG, Ill., Aug. 9, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced financial results for the quarter ended June 30, 2012.
//-->